首页> 美国卫生研究院文献>Journal of the American Medical Informatics Association : JAMIA >Editors Choice: A methodology for a minimum data set for rare diseases to support national centers of excellence for healthcare and research
【2h】

Editors Choice: A methodology for a minimum data set for rare diseases to support national centers of excellence for healthcare and research

机译:编辑推荐:一种针对罕见疾病的最低数据集的方法以支持国家医疗保健和研究卓越中心

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background Although rare disease patients make up approximately 6–8% of all patients in Europe, it is often difficult to find the necessary expertise for diagnosis and care and the patient numbers needed for rare disease research. The second French National Plan for Rare Diseases highlighted the necessity for better care coordination and epidemiology for rare diseases. A clinical data standard for normalization and exchange of rare disease patient data was proposed. The original methodology used to build the French national minimum data set (F-MDS-RD) common to the 131 expert rare disease centers is presented.>Methods To encourage consensus at a national level for homogeneous data collection at the point of care for rare disease patients, we first identified four national expert groups. We reviewed the scientific literature for rare disease common data elements (CDEs) in order to build the first version of the F-MDS-RD. The French rare disease expert centers validated the data elements (DEs). The resulting F-MDS-RD was reviewed and approved by the National Plan Strategic Committee. It was then represented in an HL7 electronic format to maximize interoperability with electronic health records.>Results The F-MDS-RD is composed of 58 DEs in six categories: patient, family history, encounter, condition, medication, and questionnaire. It is HL7 compatible and can use various ontologies for diagnosis or sign encoding. The F-MDS-RD was aligned with other CDE initiatives for rare diseases, thus facilitating potential interconnections between rare disease registries.>Conclusions The French F-MDS-RD was defined through national consensus. It can foster better care coordination and facilitate determining rare disease patients’ eligibility for research studies, trials, or cohorts. Since other countries will need to develop their own standards for rare disease data collection, they might benefit from the methods presented here.
机译:>背景尽管在欧洲,罕见病患者约占所有患者的6–8%,但通常很难找到诊断和护理所需的专业知识以及罕见病研究所需的患者人数。法国的第二个国家罕见病计划强调了对稀有疾病进行更好的护理协调和流行病学的必要性。提出了一种临床数据标准,用于规范和交换罕见病患者数据。介绍了用于建立131个专家罕见病中心通用的法国国家最低数据集(F-MDS-RD)的原始方法。>方法为了鼓励在国家层面上就在全国范围内收集同类数据达成共识在罕见病患者的护理点上,我们首先确定了四个国家专家组。我们审查了罕见病常见数据元素(CDE)的科学文献,以构建F-MDS-RD的第一个版本。法国罕见病专家中心对数据元素(DE)进行了验证。最终的F-MDS-RD已由国家计划战略委员会审查和批准。然后以HL7电子格式表示该文件,以最大程度地提高与电子健康记录的互操作性。>结果 F-MDS-RD由58种DE组成,分为六个类别:患者,家族史,遭遇,状况,药物以及问卷。它与HL7兼容,可以使用各种本体进行诊断或符号编码。 F-MDS-RD与其他针对稀有疾病的CDE计划保持一致,从而促进了稀有疾病注册机构之间的潜在联系。>结论法国F-MDS-RD是通过国家共识来定义的。它可以促进更好的护理协调,并有助于确定罕见病患者的研究,试验或队列资格。由于其他国家将需要制定自己的罕见病数据收集标准,因此它们可能会从此处介绍的方法中受益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号